HDL Proteome in Hemodialysis Patients: A Quantitative Nanoflow Liquid Chromatography-Tandem Mass Spectrometry Approach

Aside from a decrease in the high-density lipoprotein (HDL) cholesterol levels, qualitative abnormalities of HDL can contribute to an increase in cardiovascular (CV) risk in end-stage renal disease (ESRD) patients undergoing chronic hemodialysis (HD). Dysfunctional HDL leads to an alteration of reve...

Full description

Bibliographic Details
Main Authors: Mangé, Alain, Goux, Aurélie, Badiou, Stéphanie, Patrier, Laure, Canaud, Bernard, Maudelonde, Thierry, Cristol, Jean-Paul, Solassol, Jérôme
Format: Online
Language:English
Published: Public Library of Science 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309955/